(Q28742977)

English

NSAID use selectively increases the risk of non-fatal myocardial infarction: a systematic review of randomised trials and observational studies

scientific article (publication date: 8 February 2011)

In more languages

Statements

scholarly article

0 references

6 references

19 March 2019

22 March 2019

17 June 2019

19 September 2019

28 October 2020

19 July 2021

systematic review

1 reference

based on heuristic

inferred from title

NSAID use selectively increases the risk of non-fatal myocardial infarction: a systematic review of randomised trials and observational studies (English)

0 references

myocardial infarction

5 references

19 March 2019

22 March 2019

17 June 2019

19 September 2019

28 October 2020

biomedical investigative technique

1 reference

19 September 2019

non-steroidal anti-inflammatory drug

1 reference

28 October 2020

anti-inflammatory agent

1 reference

19 July 2021

systematic review

1 reference

based on heuristic

inferred from title

object named as

Héctor Bueno

3

0 references

author name string

Luis Alberto García Rodríguez

1

0 references

Antonio González-Pérez

2

0 references

John Hwa

4

0 references

language of work or name

0 references

publication date

8 February 2011

6 references

19 March 2019

22 March 2019

17 June 2019

19 September 2019

28 October 2020

19 July 2021

6 references

19 March 2019

22 March 2019

17 June 2019

19 September 2019

28 October 2020

19 July 2021

6

0 references

2

0 references

e16780

0 references

copyright license

Creative Commons Attribution 4.0 International

6 references

Europe PubMed Central

19 March 2019

Europe PubMed Central

22 March 2019

Europe PubMed Central

17 June 2019

Europe PubMed Central

19 September 2019

Europe PubMed Central

28 October 2020

Europe PubMed Central

19 July 2021

copyright status

0 references

on focus list of Wikimedia project

0 references

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

16 March 2017

Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

16 March 2017

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

16 March 2017

Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

16 March 2017

Low-dose aspirin for the prevention of atherothrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

16 March 2017

The use of nonsteroidal anti-inflammatory drugs (NSAIDs): a science advisory from the American Heart Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

16 March 2017

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

16 March 2017

Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

16 March 2017

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

16 March 2017

Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

16 March 2017

Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

16 March 2017

Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

16 March 2017

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

16 March 2017

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

16 March 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

23 March 2017

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

7 April 2017

Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

3 June 2018

Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

3 June 2018

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

3 June 2018

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

3 June 2018

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

3 June 2018

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

3 June 2018

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

3 June 2018

Clinical pharmacology of platelet cyclooxygenase inhibition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3035655

3 June 2018

Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016780

21 January 2018

Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016780

21 January 2018

Expression of concern reaffirmed

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016780

21 January 2018

Use of non-steroidal antiinflammatory drugs and type-specific risk of acute coronary syndrome.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0016780

21 January 2018

Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment of Colorectal Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21347435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0016780

0 references

2011PLoSO...616780G

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28742977&oldid=1730746433"